MoonLake Immunotherapeutics
MLTX
#3816
Rank
NZ$4.46 B
Marketcap
$70.53
Share price
-4.91%
Change (1 day)
-11.86%
Change (1 year)

MoonLake Immunotherapeutics (MLTX) - P/B ratio

P/B ratio as of March 2025 : 5.12

According to MoonLake Immunotherapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

MoonLake Immunotherapeutics - P/B ratio (from 2022 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-317.05-0.03%
2023-12-317.0518.45%
2022-12-315.95
2021-12-31N/A